Status:
COMPLETED
UCB Stem Cells for Autism Spectrum Disorders
Lead Sponsor:
St. Petersburg Bekhterev Research Psychoneurological Institute
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
3-11 years
Phase:
PHASE1
Brief Summary
Purpose. The goals of the study are to assess the safety of the intravenous infusion of umbilical cord blood (UCB) cells in patients with autism and to confirm changes in social/ communicative skills ...
Eligibility Criteria
Inclusion
- diagnosed ASD by ICD-10 criteria
Exclusion
- acute somatic diseases
- indication for surgical (neurosurgical) therapy
- acute or chronic infectious diseases
- history of acute allergic reactions
Key Trial Info
Start Date :
November 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04710810
Start Date
November 4 2019
End Date
July 31 2021
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St.-Petersburg Bekhterev Reserach Psychoneurological Institute
Saint Petersburg, Sankt-Peterburg, Russia, 192019